MUZAMAL HOLDINGS SDN BHD: Company Profile
Background
Overview
MUZAMAL HOLDINGS SDN BHD, established on September 25, 1998, is a Malaysian company specializing in the production and distribution of medical devices and consumables. The company operates through its subsidiaries, including Muzamal Industries Sdn Bhd, Muzaglobal Sdn Bhd, and Intaniaga Sdn Bhd, focusing on manufacturing and marketing medical products such as hypodermic syringes, needles, specimen containers, and surgical sutures.
Mission and Vision
- Mission: To promote, strengthen, and maintain brand loyalty among new and existing customers by meeting their stringent demands for quality products.
- Vision: To extend the market for our products and be recognized as a trusted, reliable, and professional supplier of medical products at an international level.
Industry Significance
MUZAMAL HOLDINGS plays a pivotal role in Malaysia's medical device manufacturing sector, contributing to the healthcare industry's supply chain by providing essential medical consumables that adhere to international quality standards.
Key Strategic Focus
Core Objectives
- Enhance product quality and innovation to meet global healthcare standards.
- Expand market presence both domestically and internationally.
- Maintain strict adherence to quality control and regulatory compliance.
Areas of Specialization
- Manufacturing of single-use hypodermic syringes and needles.
- Production of specimen containers for medical testing.
- Development of absorbable and non-absorbable surgical sutures.
Key Technologies Utilized
- ISO 14644 Class 8 cleanroom facilities for sterile manufacturing.
- Advanced quality control systems ensuring compliance with international standards.
Primary Markets Targeted
- Domestic healthcare institutions and medical organizations.
- International markets, with a focus on regions such as Hong Kong and the United Kingdom.
Financials and Funding
Funding History
Specific details regarding MUZAMAL HOLDINGS' funding history, including total funds raised and recent funding rounds, are not publicly disclosed.
Recent Financial Performance
- Net Sales Revenue: Increased by 0.1% in 2024.
- Total Assets: Grew by 7.05% in 2024.
- Net Profit Margin: Improved by 3.1% in 2024.
Utilization of Capital
While specific details on the utilization of capital are not publicly available, it is likely allocated towards:
- Expansion of manufacturing facilities.
- Research and development for new product lines.
- Enhancement of quality control and compliance measures.
Pipeline Development
Key Pipeline Candidates
MUZAMAL HOLDINGS continues to develop and refine its product offerings, focusing on:
- Innovative hypodermic syringes and needles.
- Advanced surgical sutures.
- Specialized specimen containers.
Stages of Development
The company is engaged in ongoing research and development to enhance existing products and introduce new ones, ensuring they meet international standards and market demands.
Target Conditions
Products are designed to address a wide range of medical procedures, including:
- Injection and fluid extraction.
- Wound closure.
- Specimen collection for diagnostic testing.
Anticipated Milestones
Specific timelines for product development milestones are not publicly disclosed.
Technological Platform and Innovation
Proprietary Technologies
- ISO 14644 Class 8 cleanroom facilities for sterile manufacturing.
- Advanced quality control systems ensuring compliance with international standards.
Significant Scientific Methods
- Adherence to Malaysia Regulation, United States Pharmacopeia (USP), European Pharmacopeia (EP), and European Standards of Medical Device Directive (MDD) requirements.
- Implementation of stringent quality control procedures and hygiene practices.
Leadership Team
Key Executives
- Muhammad Muza Muhayen: CEO, leading strategic direction and operations.
- Teguh Setiabudhi: Sales Specialist, responsible for market expansion and customer relations.
- Nurazura Sudin: Regulatory Affairs Executive, ensuring compliance with industry regulations.
- Fatimah Sulaiha: Quality Control Manager, overseeing product quality and standards.
Leadership Changes
No recent significant changes or appointments within the company's leadership have been publicly disclosed.
Competitor Profile
Market Insights and Dynamics
The medical device manufacturing industry in Malaysia is characterized by:
- A growing demand for quality medical consumables.
- Competitive pricing pressures.
- Stringent regulatory requirements.
Competitor Analysis
Key competitors in the Malaysian market include:
- MUMAZ HOLDINGS SDN BHD: Engages in manufacturing, importing, exporting, retailing, and supplying various products, including bricks and construction materials.
- Naim Holdings Berhad:
